Multichannel
Getting ready for primetime in cell & gene therapy
As thousands of novel cell and gene therapies advance along the development pipeline, pressure mounts for scalable treatments
More Articles
Commercial
Building a commercial dream team for today’s pharma industry
The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams
Patients and Medical
Digital Health: Letting human nature drive design
End users are increasingly important partners in developing digital health solutions, to the benefit of all
Access and Evidence
RWE’s new dataset: Social media
Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond
Multichannel
Scaling CGT through automation
Delivering on the promise of cell and gene therapies requires significant process improvements to cut manufacturing time and costs
Patients and Medical
Advancing health equity for the LGBTQIA+ community
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help.
Commercial
Omnichannel: How will pharma get there?
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management
Patients and Medical
Advocacy in Hemophilia: Building the Future by Design
Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking
Commercial
Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble
Patients and Medical
Bringing hope in hemophilia
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment